Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction

Current Medical Research and Opinion

Volumn 24, Issue 3, 2008, Pages 775-784

  McVary, Kevin T ^a   Foley, Kathleen A ^b   Long, Stacey R ^b   Sander, Stephen ^c   Curtice, Tammy G ^c   Shah, Hemal ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Outcomes Research and Econometrics   (United States)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Alpha adrenergic receptor antagonists; Benign prostate hyperplasia; Erectile dysfunction; Lower urinary tract symptoms

Indexed keywords

ALFUZOSIN; DOXAZOSIN; DUTASTERIDE; FINASTERIDE; PAPAVERINE; PHENTOLAMINE; SILDENAFIL; TADALAFIL; TAMSULOSIN; TERAZOSIN; VARDENAFIL;

ADULT; ARTICLE; BILLING AND CLAIMS; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; SCREENING; UNITED STATES;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; ERECTILE DYSFUNCTION; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; URINATION DISORDERS;

EID: 41149130243     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X260916     Document Type: Article

References (29)

1. Berry S, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-9
2. Mariappan P, Chong WL. Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: results of a regional population-based survey and comparison with industrialized nations. BJU Int 2006;98:1264-8
3. Liu CC, Huang SP, Li WM, et al. Are lower urinary tract symptoms associated with erectile dysfunction in aging males of Taiwan? Urol Int 2006;77:251-4
4. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44:637-49
5. Stroberg P, Boman H, Gellerstedt M, et al. Relationships between lower urinary tract symptoms, the bother they induce and erectile dysfunction. Scand J Urol Nephrol 2006;40:307-12
6. Asian G, Cavus E, Karas H, et al. Association between lower urinary tract symptoms and erectile dysfunction. Arch Androl 2006;52:155-62
7. Paick SH, Meehan A, Lee M, et al. The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the Proscar long-term efficacy and safety study. J Urol 2005;173:903-7
8. Zakaria L, Anastasiadis AG, Shabsigh R. Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression. Int Urol Nephrol 2001;33:283-92
9. Frankel SJ, Donovan JL, Peters TI, et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1988;51:677-85
10. McVary KT, McKenna KE. The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical, and basic science evidence. Curr Urol Rep 2004;5:251-7
11. McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 2006;97(Suppl 2):23-8
12. Bloch W, Klotz T, Loch C, et al. Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide. Prostate 1997;3:1-8
13. Felsen D, Dardashti K, Ostad M, et al. Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction. J Urol 2003;169:1569-72
14. Golomb E, Rosenzweig N, Eilam R, et al. Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats. J Androl 2000;21:58-64
15. Persson K, Pandita RK, Spitsbergen JM, et al. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am J Physiol 1998;275(4 Pt 2):R1366-73
16. Behr-Roussel D, Chamiot-Clerc P, Bernabe J, et al. Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003;284:R682-8
17. Chang S, Hypolite JA, Zderic SA, et al. Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Am J Physiol Regul Integr Comp Physiol 2005;289:R1124-30
18. Bing W, Chang S, Hypolite JA, et al. Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am J Physiol Renal Physiol 2003;285:F990-7
19. Azadzoi KM, Babayan RK, Kozlowski R, et al. Chronic ischemia increases prostatic smooth muscle contraction in the rabbit. J Urol 2003;170(2 Pt 1):659-63
20. Azadzoi KM, Tarcan T, Siroky MB, et al. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit. J Urol 1999;161:1626-35
21. Kozlowski R, Kershen RT, Siroky MB, et al. Chronic ischemia alters prostate structure and reactivity in rabbits. J Urol 2001;165:1019-26
22. Wei JT, Calhoun EA, Jacobsen SJ. Benign Prostatic Hyperplasia. In: Litwin MS, Saigal CS, eds. Urologic Diseases in America. DHHS, PHS, NIH, NIDDK. Washington, DC: GPO, 2004; NIH Publication No. 04-5512:43-67
23. Wei JT, Calhoun EA, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005;173:1256-61
24. Verhamme KM, Dieleman JP, Bleumink GS, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - the Triumph project. Eur Urol 2002;42:323-8
25. McVary KT. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 2005;47:838-45
26. McVary KT, Roehrborn CG, Kaminetsky JC, et al. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2007;177:1401-7
27. McVary KT, Monnig W, Camps JL Jr, et al. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 2007;177:1071-7
28. McVary KT, Rademaker A, Lloyd GL, et al. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2005;174(4 Pt 1):1327-433
29. Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999;16:1-8